{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:19:27Z","timestamp":1769689167130,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,7,3]],"date-time":"2010-07-03T00:00:00Z","timestamp":1278115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10549-010-1004-y","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T06:29:42Z","timestamp":1278052182000},"page":"375-384","source":"Crossref","is-referenced-by-count":35,"title":["Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER\/EphA2-positive breast cancer"],"prefix":"10.1007","volume":"127","author":[{"given":"Yesim","family":"G\u00f6kmen-Polar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel A.","family":"Toroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Hocevar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Badve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Bruckheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Kinch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,3]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(00)80500-0","volume":"90","author":"Eph Nomenclature Committee","year":"1997","unstructured":"Eph Nomenclature Committee (1997) Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 90:403\u2013404","journal-title":"Cell"},{"key":"1004_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","volume":"133","author":"EB Pasquale","year":"2008","unstructured":"Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133:38\u201352","journal-title":"Cell"},{"key":"1004_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/bcr2207","volume":"10","author":"D Vaught","year":"2008","unstructured":"Vaught D, Brantley-Sieders DM, Chen J (2008) Eph receptors in breast cancer: roles in tumor promotion and tumor suppression. Breast Cancer Res 10:217","journal-title":"Breast Cancer Res"},{"key":"1004_CR4","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1128\/MCB.10.12.6316","volume":"10","author":"RA Lindberg","year":"1990","unstructured":"Lindberg RA, Hunter T (1990) cDNA cloning, characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph\/elk family of protein kinases. Mol Cell Biol 10:6316\u20136324","journal-title":"Mol Cell Biol"},{"key":"1004_CR5","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/1541-7786.MCR-08-0244","volume":"6","author":"J Wykosky","year":"2008","unstructured":"Wykosky J, Debinski W (2008) The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Mol Cancer Res 6:1795\u20131806","journal-title":"Mol Cancer Res"},{"key":"1004_CR6","first-page":"2301","volume":"61","author":"DP Zelinski","year":"2001","unstructured":"Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS (2001) EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res 61:2301\u20132306","journal-title":"Cancer Res"},{"key":"1004_CR7","first-page":"3640","volume":"7","author":"ND Zantek","year":"2001","unstructured":"Zantek ND, Walker-Daniels J, Stewart J, Hansen RK, Robinson D, Miao H, Wang B, Kung HJ, Bissell MJ, Kinch MS (2001) MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer. Clin Cancer Res 7:3640\u20133648","journal-title":"Clin Cancer Res"},{"key":"1004_CR8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jcb.10186","volume":"85","author":"DP Zelinski","year":"2002","unstructured":"Zelinski DP, Zantek ND, Walker-Daniels J, Peters MA, Taparowsky EJ, Kinch MS (2002) Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase. J Cell Biochem 85:714\u2013720","journal-title":"J Cell Biochem"},{"key":"1004_CR9","first-page":"629","volume":"10","author":"ND Zantek","year":"1999","unstructured":"Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R, Kinch MS (1999) E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 10:629\u2013638","journal-title":"Cell Growth Differ"},{"key":"1004_CR10","doi-asserted-by":"crossref","unstructured":"Pan M (2005) Overexpression of EphA2 gene in invasive human breast cancer and its association with hormone receptor status [ASCO annual meeting proceedings]. J Clin Oncol 23:9583","DOI":"10.1200\/jco.2005.23.16_suppl.9583"},{"key":"1004_CR11","doi-asserted-by":"crossref","first-page":"e2994","DOI":"10.1371\/journal.pone.0002994","volume":"3","author":"KJ Martin","year":"2008","unstructured":"Martin KJ, Patrick DR, Bissell MJ, Fournier MV (2008) Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS One 3:e2994","journal-title":"PLoS One"},{"key":"1004_CR12","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1158\/0008-5472.CAN-06-0515","volume":"66","author":"MV Fournier","year":"2006","unstructured":"Fournier MV, Martin KJ, Kenny PA et al (2006) Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res 66:7095\u20137102","journal-title":"Cancer Res"},{"key":"1004_CR13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbrc.2004.04.102","volume":"318","author":"BP Fox","year":"2004","unstructured":"Fox BP, Kandpal RP (2004) Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem Biophys Res Commun 318:882\u2013892","journal-title":"Biochem Biophys Res Commun"},{"key":"1004_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI33154","volume":"118","author":"DM Brantley-Sieders","year":"2008","unstructured":"Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J (2008) The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Investig 118:64\u201378","journal-title":"J Clin Investig"},{"key":"1004_CR15","first-page":"3425","volume":"63","author":"M Lu","year":"2003","unstructured":"Lu M, Miller KD, G\u00f6kmen-Polar Y, Jeng MH, Kinch MS (2003) EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity. Cancer Res 63:3425\u20133429","journal-title":"Cancer Res"},{"key":"1004_CR16","first-page":"2840","volume":"62","author":"K Carles-Kinch","year":"2002","unstructured":"Carles-Kinch K, Kilpatrick KE, Stewart JC, Kinch MS (2002) Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res 62:2840\u20132847","journal-title":"Cancer Res"},{"key":"1004_CR17","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116\u20135121","journal-title":"Proc Natl Acad Sci USA"},{"key":"1004_CR18","doi-asserted-by":"crossref","unstructured":"G\u00f6kmen-Polar Y, Mehta R, Tuzmen S, Mousses S, Thorat MA, Sanders KL, Turbin D, Leung S, Huntsman DG, Sledge GW Jr, Badve S (2010) Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes. Breast Cancer Res Treat. doi: 10.1007\/s10549-010-0733-2","DOI":"10.1007\/s10549-010-0733-2"},{"key":"1004_CR19","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1158\/0008-5472.CAN-08-1845","volume":"69","author":"M Parri","year":"2009","unstructured":"Parri M, Taddei ML, Bianchini F, Calorini L, Chiarugi P (2009) EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res 69:2072\u20132081","journal-title":"Cancer Res"},{"key":"1004_CR20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0092-8674(02)00641-4","volume":"108","author":"NJ McKenna","year":"2002","unstructured":"McKenna NJ, O\u2019Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465\u2013474","journal-title":"Cell"},{"key":"1004_CR21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/mi.5.6.7","volume":"5","author":"JM Hall","year":"2005","unstructured":"Hall JM, McDonnell DP (2005) Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interv 5:343\u2013357","journal-title":"Mol Interv"},{"key":"1004_CR22","first-page":"447S","volume":"9","author":"R Schiff","year":"2003","unstructured":"Schiff R, Massarweh S, Shou J, Osborne CK (2003) Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res 9:447S\u2013454S","journal-title":"Clin Cancer Res"},{"key":"1004_CR23","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1158\/1078-0432.CCR-06-2316","volume":"13","author":"M Katoh","year":"2007","unstructured":"Katoh M (2007) WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13:4042\u20134045","journal-title":"Clin Cancer Res"},{"key":"1004_CR24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers H (2006) Wnt\/beta-catenin signaling in development and disease. Cell 127:469\u2013480","journal-title":"Cell"},{"key":"1004_CR25","doi-asserted-by":"crossref","first-page":"re9","DOI":"10.1126\/scisignal.135re9","volume":"1","author":"R Amerongen van","year":"2008","unstructured":"van Amerongen R, Mikels A, Nusse R (2008) Alternative Wnt signaling is initiated by distinct receptors. Sci Signal 1:re9","journal-title":"Sci Signal"},{"key":"1004_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12015-007-0001-y","volume":"3","author":"P Neth","year":"2007","unstructured":"Neth P, Ries C, Karow M, Egea V, Ilmer M, Jochum M (2007) The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. Stem Cell Rev 3:18\u201329","journal-title":"Stem Cell Rev"},{"key":"1004_CR27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ncb823","volume":"4","author":"N Carter","year":"2002","unstructured":"Carter N, Nakamoto T, Hirai H, Hunter T (2002) EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat Cell Biol 4:565\u2013573","journal-title":"Nat Cell Biol"},{"key":"1004_CR28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/35000008","volume":"2","author":"H Miao","year":"2000","unstructured":"Miao H, Burnett E, Kinch M, Simon E, Wang B (2000) Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol 2:62\u201369","journal-title":"Nat Cell Biol"},{"key":"1004_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbamcr.2004.04.008","volume":"1692","author":"DD Schlaepfer","year":"2004","unstructured":"Schlaepfer DD, Mitra SK, Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692:77\u2013102","journal-title":"Biochim Biophys Acta"},{"key":"1004_CR30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ceca.2005.06.022","volume":"38","author":"AD Kohn","year":"2005","unstructured":"Kohn AD, Moon RT (2005) Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 38:439\u2013446","journal-title":"Cell Calcium"},{"key":"1004_CR31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1083\/jcb.200212114","volume":"160","author":"DA Hsia","year":"2003","unstructured":"Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, Spencer KS, Cheresh DA, Schlaepfer DD (2003) Differential regulation of cell motility and invasion by FAK. J Cell Biol 160:753\u2013767","journal-title":"J Cell Biol"},{"key":"1004_CR32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ijc.1605","volume":"97","author":"M Kohno","year":"2002","unstructured":"Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S (2002) CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 97:336\u2013343","journal-title":"Int J Cancer"},{"key":"1004_CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1022546620495","volume":"20","author":"MS Kinch","year":"2003","unstructured":"Kinch MS, Carles-Kinch K (2003) Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer. Clin Exp Metastasis 20:59\u201368","journal-title":"Clin Exp Metastasis"},{"key":"1004_CR34","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1038\/sj.onc.1203856","volume":"19","author":"VC Dodelet","year":"2000","unstructured":"Dodelet VC, Pasquale EB (2000) Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 19:5614\u20135619","journal-title":"Oncogene"},{"key":"1004_CR35","first-page":"7907","volume":"63","author":"KT Coffman","year":"2003","unstructured":"Coffman KT, Hu M, Carles-Kinch K, Tice D, Donacki N, Munyon K, Kifle G, Woods R, Langermann S, Kiener PA, Kinch MS (2003) Differential EphA2 epitope display on normal versus malignant cells. Cancer Res 63:7907\u20137912","journal-title":"Cancer Res"},{"key":"1004_CR36","doi-asserted-by":"crossref","first-page":"331S","DOI":"10.1158\/1078-0432.CCR-031212","volume":"10","author":"R Schiff","year":"2004","unstructured":"Schiff R, Massarweh SA, Shou J, Bharwani L, Mohsin SK, Osborne CK (2004) Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance. Clin Cancer Res 10:331S\u2013336S","journal-title":"Clin Cancer Res"},{"key":"1004_CR37","doi-asserted-by":"crossref","first-page":"11954","DOI":"10.1158\/0008-5472.CAN-06-1666","volume":"66","author":"M Fan","year":"2006","unstructured":"Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, Oyer SL, Salisbury JD, Cheng AS, Li L, Abbosh PH, Huang TH, Nephew KP (2006) Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res 66:11954\u201311966","journal-title":"Cancer Res"},{"key":"1004_CR38","first-page":"1391","volume":"15","author":"Y Katoh","year":"2006","unstructured":"Katoh Y, Katoh M (2006) Comparative integromics on Ephrin family. Oncol Rep 15:1391\u20131395","journal-title":"Oncol Rep"},{"key":"1004_CR39","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1158\/1535-7163.MCT-09-0282","volume":"8","author":"Y Wang","year":"2009","unstructured":"Wang Y (2009) Wnt\/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 8:2103\u20132109","journal-title":"Mol Cancer Ther"},{"key":"1004_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1101\/gad.1760809","volume":"23","author":"K Schlessinger","year":"2009","unstructured":"Schlessinger K, Hall A, Tolwinski N (2009) Wnt signaling pathways meet Rho GTPases. Genes Dev 23:265\u2013277","journal-title":"Genes Dev"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1004-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1004-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1004-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:22:16Z","timestamp":1559236936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1004-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1004-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,3]]}}}